GlassScriptPhysician profile
Pasquale Marc Rocco
NPI 1578520060
$5,928.65
in general payments reported to CMS, 2019-2025
15 companies · $1,307 in 2025
The $1,307 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2023: $671 · 2024: $3,813 · 2025: $1,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500 · Food and Beverage: $1,449 · Travel and Lodging: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
| Food and Beverage | $1,449.07 |
| Travel and Lodging | $841.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,919.81 | 2023-2025 | Signia, Endo Gia Ultra, Eea |
| Davol INC. | $1,182.91 | 2025 | Phasix Mesh |
| Myriad Genetic Laboratories, INC. | $223.47 | 2023-2024 | Myrisk |
| Inari Medical, INC. | $141.72 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Impulse Dynamics (USA) INC. | $138.98 | 2023 | Optimizer |
| Abbvie INC. | $108.09 | 2019 | |
| Ethicon US, LLC | $37.98 | 2024 | Vistaseal |
| Janssen Biotech, INC. | $36.03 | 2023 | Stelara |
| Merck Sharp & Dohme LLC | $29.95 | 2019 | |
| Solventum Corporation | $24.65 | 2025 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Prevena |
| Becton, Dickinson and Company | $19.05 | 2024 | Phasix Mesh |
| Baxter Healthcare | $18.12 | 2024 | Tisseel |
| Braintree Laboratories, INC. | $16.24 | 2023 | Suflave, Sutab |
| Kerecis Limited | $15.83 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Pacira Pharmaceuticals Incorporated | $15.82 | 2023 | Iovera, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pasquale Rocco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.